Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramiro Garzon

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the NucleusParvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, et al.
Leukemia & Lymphoma|February 11, 2020
Phase I study of AR-42 and decitabine in acute myeloid leukemiaSophia G Liva, Christopher C Coss, Jiang Wang, et al.
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
The AAPS Journal|July 14, 2010
A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo applicationKenneth K Chan, Zhongfa Liu, Zhiliang Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Genome Medicine|October 30, 2014
A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human gliomaMarco Galasso, Paola Dama, Maurizio Previati, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the NucleusParvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, et al.
Leukemia & Lymphoma|February 11, 2020
Phase I study of AR-42 and decitabine in acute myeloid leukemiaSophia G Liva, Christopher C Coss, Jiang Wang, et al.
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
The AAPS Journal|July 14, 2010
A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo applicationKenneth K Chan, Zhongfa Liu, Zhiliang Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
Genome Medicine|October 30, 2014
A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human gliomaMarco Galasso, Paola Dama, Maurizio Previati, et al.
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
Pageof 14